University of Maryland, Baltimore, Center for Vaccine Development and Global Health

Baltimore, Maryland 21201

3 studies enrolling now · 13 studies all time

What they study most

Cholera Vaccination, Dengue, Hepatitis B Vaccination, Malaria, Malaria (Plasmodium Falciparum), Malaria,Falciparum, Pneumococcal Disease, Risk Reduction, SARS-CoV, SARS-CoV-2, Shigella, Typhoid and/or Cholera Vaccination

Studies at this site

• Blood Donor CVD 5000 — Recruiting now
• CVD 38000: Study of Responses to Vaccination With Typhoid and/or Cholera — Recruiting now
• Malaria CVD 36000; Gates INV090205 — Starting soon
• A Study to Learn About How a New Pneumococcal Vaccine Works in Children — Completed
• Dengue 4 Human Infection Model (Dengue CVD 11000; DHIM-4) — Completed
• Salmonella Conjugates CVD 1000: Study of Responses to Vaccination With Trivalent Invasive Salmonella Disease Vaccine — Completed
• ADVP005; Dengue CVD 12000 - Dengue-1-Virus Live Virus Human Challenge (DENV-1-LVHC) — Completed
• Study of VXCO-100, a SARS-CoV Candidate Vaccine in Healthy Adults in the United States — Completed
• A Phase 1 Trial of PfSPZ Vaccine in Healthy Adults to Determine Safety, Tolerability and Efficacy Against Heterologous CHMI — Stopped early
• Shigella CVD 30000: Study of Responses to Vaccination With Shigella Vaccine — Completed
• 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 4-Dose Series in Healthy Infants — Completed
• Blood Donor CVD 9000 — Stopped early
• Hepatitis B Vaccine in Seniors — Completed